m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00048)
| Target Name | S-mu-GLT (SugLT) | ||||
|---|---|---|---|---|---|
| Gene Name | S-mu-GLT | ||||
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
S-mu-GLT
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Drug
YTH domain-containing protein 1 (YTHDC1) [READER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Direct suppression of m6A modification of S-mu-GLT (SugLT) or of m6A reader YTHDC1 reduces CSR. METTL3 enzyme-catalyzed N6-methyladenosine (m6A) RNA modification drives recognition and 3' end processing of S-mu-GLT by the RNA exosome, promoting class switch recombination and suppressing chromosomal translocations. Tamoxifen affects the role of METTL3 in B cell development. | |||
| Target Regulation | Up regulation | |||
| Responsed Drug | Tamoxifen | Approved | ||
| Pathway Response | Nucleotide excision repair | hsa03420 | ||
| Cell Process | DNA repair | |||
| In-vitro Model | CH12F3 | Mouse lymphoma | Mus musculus | CVCL_E067 |
| CH12F3 | Mouse lymphoma | Mus musculus | CVCL_E067 | |
| HEK293T | Normal | Homo sapiens | CVCL_0063 | |
| In-vivo Model | 6- to 12-week-old mice were used for experiments. | |||
Tamoxifen
[Approved]
| In total 1 item(s) under this drug | ||||
| Experiment 1 Reporting the m6A-centered Drug Response | [1] | |||
| Response Summary | Direct suppression of m6A modification of S-mu-GLT (SugLT) or of m6A reader YTHDC1 reduces CSR. METTL3 enzyme-catalyzed N6-methyladenosine (m6A) RNA modification drives recognition and 3' end processing of S-mu-GLT by the RNA exosome, promoting class switch recombination and suppressing chromosomal translocations. Tamoxifen affects the role of METTL3 in B cell development. | |||
| Target Regulator | YTH domain-containing protein 1 (YTHDC1) | READER | ||
| Target Regulation | Up regulation | |||
| Pathway Response | Nucleotide excision repair | hsa03420 | ||
| Cell Process | DNA repair | |||
| In-vitro Model | CH12F3 | Mouse lymphoma | Mus musculus | CVCL_E067 |
| CH12F3 | Mouse lymphoma | Mus musculus | CVCL_E067 | |
| HEK293T | Normal | Homo sapiens | CVCL_0063 | |
| In-vivo Model | 6- to 12-week-old mice were used for experiments. | |||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Non-coding RNA
m6A Regulator: YTH domain-containing protein 1 (YTHDC1)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05553 | ||
| Epigenetic Regulator | S-mu-GLT (SugLT) | |
| Crosstalk relationship | m6A → ncRNA | |
| Drug | Tamoxifen* | |